X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12447) 12447
Publication (863) 863
Newsletter (268) 268
Newspaper Article (196) 196
Book Review (173) 173
Book Chapter (156) 156
Magazine Article (29) 29
Dissertation (26) 26
Conference Proceeding (24) 24
Book / eBook (16) 16
Trade Publication Article (8) 8
Data Set (5) 5
Reference (5) 5
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8821) 8821
female (6464) 6464
index medicus (5776) 5776
male (5679) 5679
glucose (4871) 4871
diabetes (4575) 4575
adult (4143) 4143
endocrinology & metabolism (3931) 3931
insulin resistance (3795) 3795
middle aged (3666) 3666
risk factors (3636) 3636
obesity (2846) 2846
insulin (2658) 2658
glucose tolerance test (2570) 2570
blood glucose - metabolism (2457) 2457
animals (2279) 2279
type 2 diabetes (2243) 2243
insulin-resistance (2209) 2209
aged (2177) 2177
research (2175) 2175
pregnancy (1963) 1963
diabetes mellitus (1851) 1851
prevalence (1794) 1794
health aspects (1673) 1673
dextrose (1643) 1643
body mass index (1592) 1592
metabolism (1589) 1589
hyperglycemia (1555) 1555
metabolic syndrome (1434) 1434
insulin - blood (1422) 1422
blood glucose - analysis (1416) 1416
mellitus (1336) 1336
risk (1318) 1318
physiological aspects (1287) 1287
glucose metabolism (1167) 1167
mice (1167) 1167
obesity - complications (1145) 1145
medicine (1130) 1130
glucose intolerance (1092) 1092
research article (1089) 1089
adolescent (1072) 1072
glucose intolerance - complications (1066) 1066
studies (1034) 1034
diagnosis (1033) 1033
care and treatment (1016) 1016
hypertension (1008) 1008
analysis (929) 929
diet (927) 927
diabetes-mellitus (924) 924
women (918) 918
rodents (907) 907
mortality (904) 904
impaired glucose-tolerance (901) 901
rats (898) 898
diabetes mellitus, type 2 - blood (883) 883
diabetes mellitus, type 2 - complications (878) 878
insulin - metabolism (868) 868
glucose tolerance (864) 864
complications and side effects (859) 859
nutrition & dietetics (859) 859
fasting (855) 855
medicine, general & internal (830) 830
glucose - metabolism (823) 823
blood pressure (817) 817
diabetes mellitus, type 2 - epidemiology (799) 799
cardiovascular-disease (775) 775
multidisciplinary sciences (768) 768
cardiovascular disease (766) 766
glucose intolerance - blood (756) 756
inflammation (754) 754
risk-factors (749) 749
hypoglycemic agents - therapeutic use (734) 734
disease (731) 731
oxidative stress (720) 720
complications (716) 716
body weight (710) 710
glucose intolerance - epidemiology (707) 707
cross-sectional studies (705) 705
population (705) 705
young adult (702) 702
homeostasis (700) 700
glucose-tolerance (694) 694
nutritional and metabolic diseases (690) 690
child (675) 675
glucose tolerance tests (673) 673
science (670) 670
prevention (658) 658
prospective studies (657) 657
endocrine system diseases (636) 636
metabolic disorders (633) 633
insulin resistance - physiology (627) 627
resistance (627) 627
diabetes in pregnancy (622) 622
abridged index medicus (607) 607
association (607) 607
medicine, research & experimental (597) 597
cholesterol (596) 596
physiology (591) 591
medical research (588) 588
sensitivity (582) 582
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12626) 12626
Japanese (158) 158
German (66) 66
French (61) 61
Spanish (47) 47
Chinese (30) 30
Polish (22) 22
Russian (19) 19
Italian (14) 14
Hungarian (13) 13
Portuguese (13) 13
Turkish (12) 12
Romanian (8) 8
Czech (7) 7
Korean (7) 7
Danish (5) 5
Serbian (5) 5
Arabic (4) 4
Croatian (2) 2
Norwegian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Swedish (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 16, pp. 1769 - 1780
Abstract Background Evidence suggests that interleukin (IL)-1β is important in the pathogenesis of atherosclerosis and its complications and that inhibiting... 
Cardiovascular | Internal Medicine | C-reactive protein | interleukin-1 | inflammation | homeostasis model assessment | RHEUMATOID-ARTHRITIS | MACROPHAGE PLASTICITY | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | INTERLEUKIN-1 RECEPTOR ANTAGONIST | TUMOR-NECROSIS-FACTOR | VASCULAR FUNCTION | CARDIOVASCULAR-DISEASE | E-DEFICIENT MICE | Atherosclerosis - drug therapy | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Atherosclerosis - complications | Male | Arteries - drug effects | Glucose Intolerance - complications | Female | Diabetes Mellitus, Type 2 - complications | Interleukin-1beta - antagonists & inhibitors | Type 2 diabetes | Complications and side effects | Blood circulation disorders | Medical colleges | Care and treatment | Interleukins | Atherosclerosis | Development and progression | Research institutes | Glucose | Dextrose | Proteins | Heart attacks | Nuclear magnetic resonance--NMR | Cytokines | Mortality | Inflammation | Diabetes | Patients | CI, confidence interval | T2DM, type 2 diabetes mellitus | HOMA, homeostasis model assessment | IL-1RA, interleukin-1 receptor antagonist | HbA1c, glycosylated hemoglobin | MRI, magnetic resonance imaging | GMR, geometric mean ratio | IL, interleukin | PWV, pulsed wave velocity | IGT, impaired glucose tolerance | Original Investigation | hs-CRP, high-sensitivity C-reactive protein
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
by Bosch, Jackie and Gerstein, Hertzel C and Dagenais, Gilles R and Díaz, Rafael and Dyal, Leanne and Jung, Hyejung and Maggiono, Aldo P and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, Leanne and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 309 - 318
Participants with impaired fasting glucose who were at risk for cardiovascular events were assigned to receive daily n−3 fatty acids or placebo and to receive... 
MEDICINE, GENERAL & INTERNAL | EVENTS | PREVENTION | FISH | RISK | CORONARY-HEART-DISEASE | OMEGA-3-FATTY-ACID INTAKE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Treatment Failure | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Double-Blind Method | Proportional Hazards Models | Glucose Intolerance - complications | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Complications and side effects | Care and treatment | Patient outcomes | Dietary supplements | Causes of | Diabetes | Cardiovascular diseases | Fatty acids | Health aspects | Myocardial infarction | Arrhythmia | Diabetes mellitus | Lipids | Esters | Cardiovascular disease | Insulin | Glucose tolerance | Diet | Death | Supplementation | Diabetes mellitus (non-insulin dependent) | Heart diseases | Cardiovascular Diseases | Insulin, Long-Acting | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article